<ѻýҕl>JAK Inhibitor Misses Endpoint in Safety Study. Now What?ѻýҕl> Major blow to popular class of oral rheumatology drugs Jan 27, 2021
<ѻýҕl>Montana Oncologist Fired for Misdiagnosing, Overtreating Patientsѻýҕl> But some rally around him Jan 26, 2021
<ѻýҕl>Telehealth's Security Problem; Virtual Cancer Care; Post-Pandemic Teladocѻýҕl> Emerging trends in telemedicine and telehealth Jan 25, 2021
<ѻýҕl>Ozempic Seeking High Dose OK; Thyroid Cancer Overdiagnosed in Kids?ѻýҕl> News and commentary from the endocrinology world Jan 24, 2021
<ѻýҕl>Aspirin and CRC Risk: A Curious Age Connectionѻýҕl> Implications for prophylactic recommendations, researchers say Jan 21, 2021
<ѻýҕl>Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemoѻýҕl> News, features, and commentary about cancer-related issues Jan 21, 2021
<ѻýҕl>Kardashian Makeup Artist Hrush Achemyan's Ovarian Cancerѻýҕl> Beauty influencer reveals diagnosis Jan 21, 2021
<ѻýҕl>Oncotype DX Misses on Breast Cancer Risk in Black Womenѻýҕl> Accuracy of 21-gene recurrence score worse compared with white women Jan 21, 2021
<ѻýҕl>Not Just BRCA: Large Studies ID Other Key Breast Cancer Risk Genesѻýҕl> Implications for screening and other risk-management strategies, researchers say Jan 20, 2021
<ѻýҕl>Preop RT Flunks Test in Borderline Pancreatic Cancerѻýҕl> Chemotherapy alone judged efficacious but not chemoradiation Jan 20, 2021
<ѻýҕl>Drug Hits Target in Advanced Biliary Cancerѻýҕl> Responses in up to a third of patients with FGFR inhibitor infigratinib Jan 19, 2021
<ѻýҕl>Liquid Biopsy Predicts Colon Cancer Relapse Months Before CTѻýҕl> Test for ctDNA outperformed existing biomarker, may help guide therapy Jan 17, 2021
<ѻýҕl>New Target to Attack in Stomach Cancerѻýҕl> PFS, OS improved with fibroblast growth factor receptor inhibitor in non-HER2 disease Jan 16, 2021
<ѻýҕl>Ethics Consult: Refuse Treatment for Dictator? MD/JD Weighs Inѻýҕl> You voted, now see the results and an expert's discussion Jan 15, 2021
<ѻýҕl>Copay Assistance Programs Help Patients but Confuse Them Tooѻýҕl> Insurers keep track of their use and in some cases won't apply them to patient deductibles Jan 13, 2021
<ѻýҕl>Nuanced View of Oral Sex, HPV+ Oropharyngeal Cancerѻýҕl> Age at first oral sex, 'intensity,' number of partners all influence risk Jan 13, 2021
<ѻýҕl>Is This Really Cancer?ѻýҕl> Movement builds to classify Gleason 6 prostate lesions as nonmalignant Jan 09, 2021
<ѻýҕl>Most Women Satisfied With 'Going Flat' After Mastectomyѻýҕl> Lack of surgeon support key factor in later dissatisfaction, study shows Jan 08, 2021
<ѻýҕl>Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limboѻýҕl> Rule affecting Part B drugs was to take effect Jan. 1 but was stopped by federal court orders Jan 07, 2021
<ѻýҕl>Targeted Combo Fails in EGFR-Mutant NSCLCѻýҕl> Osimertinib-bevacizumab no better than osimertinib alone Jan 07, 2021
<ѻýҕl>Baby Boys Get Cancer From Mom During Birthѻýҕl> Report highlights potential fetal implications of undiagnosed maternal cervical cancer Jan 06, 2021
<ѻýҕl>PARP Inhibitors Linked With Blood Cancer Riskѻýҕl> Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
<ѻýҕl>Young-Onset Esophageal Cancer Rapidly Increasingѻýҕl> Physicians should be on the alert for younger patients with dysphagia, researchers urge Dec 16, 2020
<ѻýҕl>Add-On HDAC Inhibitor No Help in Breast Cancerѻýҕl> PFS, OS similar to endocrine therapy alone for advanced HR+ disease Dec 15, 2020
<ѻýҕl>Broader Role for PARP Inhibitors in Breast Cancer?ѻýҕl> Responses in tumors with somatic or germline mutations related to HRD Dec 14, 2020
<ѻýҕl>Online Tool Refines Individual Risks in Breast Cancerѻýҕl> RSClin incorporates 21-gene recurrence score with tumor grade, size, and more Dec 13, 2020
<ѻýҕl>Doctor-Patient Discord in Reporting Radiation Toxicityѻýҕl> Physicians underrecognized substantial symptoms in more than half of patients Dec 11, 2020
<ѻýҕl>Non-Hodgkin Lymphoma: Bispecific Antibodies Impress in Refractory Diseaseѻýҕl> Odronextamab, epcoritamab surpass 90% response threshold in early trials Dec 11, 2020
<ѻýҕl>Adjuvant Palbociclib Fails in Early, High-Risk Breast Cancerѻýҕl> No iDFS benefit with 1 year of CDK4/6 inhibition following neoadjuvant chemotherapy Dec 10, 2020
<ѻýҕl>Chemo-Free Combo Boosts PFS in First-Line CLLѻýҕl> PI3K-delta-based regimen also topped chemoimmunotherapy in relapsed setting Dec 08, 2020
<ѻýҕl>Novel Agent Active in Refractory CMLѻýҕl> Asciminib doubles molecular response versus bosutinib after two or more prior lines of therapy Dec 08, 2020
<ѻýҕl>High-Risk Prostate Cancer Patients Can Wait 6 Months for Surgery: Studyѻýҕl> Can be considered low priority procedure during COVID-19 pandemic, researchers say Dec 08, 2020
<ѻýҕl>Gene Therapy Stops Bleeding in Hemophiliaѻýҕl> Single injection had durable effectiveness, study showed Dec 08, 2020
<ѻýҕl>Chemotherapy Improved TNBC Survival in Older Womenѻýҕl> Benefits noted in both node-negative and -positive disease, as well as for those with a comorbidity score greater than 0 Dec 08, 2020
<ѻýҕl>Tranexamic Acid May Hurt Head Trauma Survival for One Key Groupѻýҕl> Cheap antifibrinolytic given en route to hospital safe overall in registry Dec 07, 2020
<ѻýҕl>Fixed-Duration Ibrutinib-Venetoclax Promising in First-Line CLLѻýҕl> DFS at 1 year reaches 95% in patients with undetectable MRD Dec 06, 2020
<ѻýҕl>CRISPR-Based Tx Offers Hope in Tough-to-Treat Blood Disordersѻýҕl> Success with investigational use of gene editing in sickle cell disease, beta-thalassemia Dec 06, 2020
<ѻýҕl>Blood Cancers and COVID-19: 'A Medically Vulnerable' Groupѻýҕl> Patients with hematologic malignancies and SARS-CoV-2 face higher risks for infection, death Dec 06, 2020
<ѻýҕl>JAK Inhibitor Wins in Second-Line Chronic GVHDѻýҕl> Twice as many patients achieved a response at week 24 Dec 05, 2020
<ѻýҕl>Sickle Cell Disease Tied to Worse COVID-19 Outcomesѻýҕl> Black patients seem to be at higher risk for certain COVID-19 complications, death Dec 05, 2020